Role of leptin and its receptor in human obesity

Current Opinion in Endocrinology and Diabetes

Volumn 4, Issue 2, 1997, Pages 164-171

  Lönnqvist, Fredrik ^a   Schalling, Martin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344890009     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199704000-00014     Document Type: Article

References (58)

1. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149:1514-1520.
2. Björntorp P: Metabolic implications of body fat distribution. Diabetes Care 1991, 14:1132-1143.
3. Frayn KN, Coppack SW: Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 1992, 82:1-6.
4. Bouchard C, Pérusse L: Genetics of obesity. Annu Rev Nutr 1993, 13:337-354.
5. Kopelman PG, Finer N, Fox KR, Hill A, McDonald IA: ASO consensus statement on obesity. Int J Obes 1994, 18:189-191.
6. Brobeck JR: Food intake as mechanism of temperature regulation. Yale J Biol Med 1948, 20:545-552.
7. Kennedy GC: Role of depot fat in hypothalamic control of food intake in rat. Proc R Soc London [Biol] 1953, 140:578-592.
8. Ingalls AM, Dickie MM, Snell GD: Obese, new mutation in house mouse. J Hered 1950, 41:317-318.
9. Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148.
10. Friedman JM, Leibel RD, Siegel DS, Walsh J, Bahary N: Molecular mapping of the mouse ob mutation. Genomes 1991, 11:1054-1062.
11. Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
12. Green ED, Maffei M, Braden VV, Proenca R, DeSilva U, Zhang Y, Streamson CC, Leibel R, Weissenbach J, Friedman JM: The human obese (ob) gene: expression pattern and mapping on the physical, cytogenic, and genetic maps of chromosome 7. Genome Res 1995, 5:5-12.
13. Stephens TW, Basinski M, Bristow M, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffman J, Hsiung HM, Kriauciunas A, et al.: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995, 377:530-532.
14. Caro J, Kolazcynski JW, Nyce MR, Ohannesian JP, Opentatova I, Goldman WH, Lynn RB, Zhang P-L, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996, 348:159-161. Presentation of a new possible mechanism for leptin resistance in obesity in humans as an alternative to central leptin receptor resistance.
15. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr.: Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 1996, 2:589-591.
16. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549.
17. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
18. Haalas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reduction effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
19. Chehab FF, Lim ME, Ronghua LU: Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996, 12:318-320.
20. Anima RS, Prabakaran D, Mantzoros C, Daqing Qu, Lowell B, Maratos Flier E, Flier J: Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
21. Saladin R, De Vos P, Guerre Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase after obese gene expression after food intake or insulin administration. Nature 1995, 377:527-529.
22. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995, 1:1311-1314.
23. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996, 45:531-535.
24. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 1995, 44:1467-1470.
25. Devos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids by body weight loss and reduced food intake. J Biol Chem 1995, 270:15958-15961.
26. Tartaglia L, Dembski L, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al.: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271. The important original identification of a leptin receptor in the mouse.
27. Gwo-Hwa L, Proenca R, Montez JM, Caroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:632-635. A thorough characterization of all leptin receptor variants and their possible roles. Presentation of the blood-brain barrier leptin receptor and the hypothalamic leptin receptor, which is abnormally spliced in db/db mice.
28. Woods AJ, Stock MJ: Leptin activation in hypothalamus. Nature 1996, 381:745.
29. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, et al.: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
30. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffell M, Friedman JM: Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genen 1996, 14:95-97.
31. Streamson CC, Chung WK, Wu-Peng S, Zhang Y, Liu S-M, Tartaglia L, Leibel RL: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271:994-996.
32. Dourish CT, Rycroft W, Iversen SD: Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 1989, 245:1509-1511.
33. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jenrenaud B: Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia 1996, 39:353-356.
34. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CT, Hess JF: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996, 13:18-19.
35. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, et al.: A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382:168-171. The original description of a receptor subtype with a central role in the leptin feedback loop system that regulates food intake.
36. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996, 381:415-418. Neuropeptide Y knockout experiments demonstrating that NPY could not be the only mechanism through which food intake is regulated.
37. Daqing QU, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek J, Kanarek R, Maratos-Flier E: A role for melatonin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
38. Lönnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in human obese subjects. Nat Med 1995, 1:950-953. One of the very first demonstrations of upregulation of leptin expression in obese subjects, particularly women.
39. Hamilton BS, Paglia D, Kwan AYM, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995, 1:953-956.
40. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF: Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995, 95:2986-2988.
41. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995, 1:1155-1161.
42. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee U, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295. One of the very first demonstrations of the relationship between serum leptin and percentage of body fat in humans.
43. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro J: Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996, 97:1344-1347.
44. Klein S, Coppack SW, Mohamed-Ali V, Landt M: Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996, 45:984-987.
45. Maffei M, Stoffel M, Barone M, Moon B, Dammerman M, Ravussin E, Bogardus C, Ludwig DS, Flier JS, Talley M, Auerbach S, Friedman J: Absence of mutations in the human ob gene in obese/diabetic subjects. Diabetes 1996, 45:679-682.
46. Clement K, Garner C, Hager J, Philippi A, LeDuc S, Carey A, Harris TJR, Jury C, Cardon LR, Basdevant A, Demenais F, Guy-Grand B, North M, Froguel P: Indication for linkage of the human ob gene region with extreme obesity. Diabetes 1996, 45:691-694.
47. Reed DR, Ding Y, Zu W, Cather C, Green ED, Price RA: Extreme obesity may be linked to markers flanking the human ob gene. Diabetes 1996, 45:691-694.
48. Comings DE, Gade R, MacMurray JP, Muhleman D, Peters WR: Genetic variants of the human obesity (ob) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry 1996, 1:325-335.
49. Haffner SM, Stem MP, Miettinen H, Wei M, Gingerich RL: Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996, 45:822-824.
50. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996, 274:1377-1379. Demonstration of a possible link between obesity and non-insulin dependent diabetes.
51. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 1996, 274:1185-1188.
52. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996, 45:695-698.
53. Vidal H, Auboeuf D, De Vos P, Staels B, Riou JP, Auwerx J, Laville M: The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 1996, 98:251-255.
54. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro J: Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996, 45:699-701.
55. Mantzoros CS, Daqing QU, Frederich RC, Susulic VS, Lowell BB, Maratos-Flier E, Flier JS: Activation of β3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 1996, 45:909-914.
56. Collins S, Surwit RS: Pharmacological manipulation of ob gene expression in a dietary model of obesity. J Biol Chem 1996, 16:9437-9440.
57. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR: Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters. J Clin Invest 1996, 97:2152-2157. A study demonstrating an influence of cytokines on leptin feedback system regulation and appetite.
58. De Vos P, Lefebvre A-M, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 1996, 98:632-635.